Details

Last Funding Type

Series D

Last Funding Money Raised

$14M

Industries

Biopharma,Biotechnology,Health Care,Pharmaceutical,Therapeutics

Founded date

Jan 1, 1996

Number Of Employee

51 - 100

Operating Status

Close

Myogen is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders. They believe that our advanced understanding of the biology of cardiovascular disease combined with their clinical development expertise in cardiovascular therapeutics provide us with the capability to discover novel therapies, as well as identify, license or
acquire products that address serious, debilitating cardiovascular disorders that are not adequately treated with existing therapies.